• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可吸入 DDA/TDB 脂质体佐剂的工程设计:喷雾干燥工艺优化的质量源于设计方法。

Engineering of an inhalable DDA/TDB liposomal adjuvant: a quality-by-design approach towards optimization of the spray drying process.

机构信息

Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100, Copenhagen O, Denmark.

出版信息

Pharm Res. 2013 Nov;30(11):2772-84. doi: 10.1007/s11095-013-1096-2. Epub 2013 Jun 22.

DOI:10.1007/s11095-013-1096-2
PMID:23794038
Abstract

PURPOSE

The purpose of this study was to identify and optimize spray drying parameters of importance for the design of an inhalable powder formulation of a cationic liposomal adjuvant composed of dimethyldioctadecylammonium (DDA) bromide and trehalose-6,6'-dibehenate (TDB).

METHODS

A quality by design (QbD) approach was applied to identify and link critical process parameters (CPPs) of the spray drying process to critical quality attributes (CQAs) using risk assessment and design of experiments (DoE), followed by identification of an optimal operating space (OOS). A central composite face-centered design was carried out followed by multiple linear regression analysis.

RESULTS

Four CQAs were identified; the mass median aerodynamic diameter (MMAD), the liposome stability (size) during processing, the moisture content and the yield. Five CPPs (drying airflow, feed flow rate, feedstock concentration, atomizing airflow and outlet temperature) were identified and tested in a systematic way. The MMAD and the yield were successfully modeled. For the liposome size stability, the ratio between the size after and before spray drying was modeled successfully. The model for the residual moisture content was poor, although, the moisture content was below 3% in the entire design space. Finally, the OOS was drafted from the constructed models for the spray drying of trehalose stabilized DDA/TDB liposomes.

CONCLUSIONS

The QbD approach for the spray drying process should include a careful consideration of the quality target product profile. This approach implementing risk assessment and DoE was successfully applied to optimize the spray drying of an inhalable DDA/TDB liposomal adjuvant designed for pulmonary vaccination.

摘要

目的

本研究旨在确定和优化喷雾干燥参数,以设计一种由二甲基双十八烷基溴化铵(DDA)和海藻糖-6,6'-二硬脂酸酯(TDB)组成的阳离子脂质体佐剂的可吸入粉末制剂。

方法

采用质量源于设计(QbD)方法,通过风险评估和实验设计(DoE),将喷雾干燥过程的关键工艺参数(CPP)与关键质量属性(CQA)联系起来,然后确定最佳操作空间(OOS)。进行了中心复合面心设计,然后进行多元线性回归分析。

结果

确定了 4 个 CQA;空气动力学质量中值直径(MMAD)、脂质体在加工过程中的稳定性(大小)、水分含量和收率。以系统的方式确定和测试了 5 个 CPP(干燥气流、进料流速、进料浓度、雾化气流和出口温度)。成功地对 MMAD 和收率进行了建模。对于脂质体粒径稳定性,成功地对喷雾干燥前后的粒径比进行了建模。残留水分含量的模型较差,尽管在整个设计空间中水分含量都低于 3%。最后,从构建的喷雾干燥海藻糖稳定的 DDA/TDB 脂质体模型中起草了 OOS。

结论

喷雾干燥工艺的 QbD 方法应包括仔细考虑质量目标产品特性。这种实施风险评估和 DoE 的方法成功地应用于优化设计用于肺部接种的可吸入 DDA/TDB 脂质体佐剂的喷雾干燥。

相似文献

1
Engineering of an inhalable DDA/TDB liposomal adjuvant: a quality-by-design approach towards optimization of the spray drying process.可吸入 DDA/TDB 脂质体佐剂的工程设计:喷雾干燥工艺优化的质量源于设计方法。
Pharm Res. 2013 Nov;30(11):2772-84. doi: 10.1007/s11095-013-1096-2. Epub 2013 Jun 22.
2
Designing CAF-adjuvanted dry powder vaccines: spray drying preserves the adjuvant activity of CAF01.设计 CAF 佐剂干粉疫苗:喷雾干燥法保持 CAF01 的佐剂活性。
J Control Release. 2013 May 10;167(3):256-64. doi: 10.1016/j.jconrel.2013.01.031. Epub 2013 Feb 8.
3
Engineering of a novel adjuvant based on lipid-polymer hybrid nanoparticles: A quality-by-design approach.基于脂质-聚合物杂化纳米粒子的新型佐剂工程:一种基于质量设计的方法。
J Control Release. 2015 Jul 28;210:48-57. doi: 10.1016/j.jconrel.2015.05.004. Epub 2015 May 6.
4
Trehalose preserves DDA/TDB liposomes and their adjuvant effect during freeze-drying.海藻糖在冻干过程中可保存二癸酰磷脂酸/结核分歧杆菌细胞壁提取物脂质体及其佐剂效应。
Biochim Biophys Acta. 2007 Sep;1768(9):2120-9. doi: 10.1016/j.bbamem.2007.05.009. Epub 2007 May 13.
5
Th1 immune responses can be modulated by varying dimethyldioctadecylammonium and distearoyl-sn-glycero-3-phosphocholine content in liposomal adjuvants.Th1 免疫应答可以通过改变脂质体佐剂中二甲氨基十八烷基[二(十八烷酰基)]-氯化铵和二硬脂酰基-sn-甘油-3-磷酸胆碱的含量来调节。
J Pharm Pharmacol. 2014 Mar;66(3):358-66. doi: 10.1111/jphp.12173. Epub 2013 Nov 19.
6
Lipid conjugation of TLR7 agonist Resiquimod ensures co-delivery with the liposomal Cationic Adjuvant Formulation 01 (CAF01) but does not enhance immunopotentiation compared to non-conjugated Resiquimod+CAF01.TLR7 激动剂瑞喹莫德的脂质缀合确保了与脂质体阳离子佐剂制剂 01(CAF01)的共递呈,但与未缀合的瑞喹莫德+CAF01 相比,并未增强免疫增强作用。
J Control Release. 2018 Dec 10;291:1-10. doi: 10.1016/j.jconrel.2018.10.002. Epub 2018 Oct 3.
7
Protein antigen adsorption to the DDA/TDB liposomal adjuvant: effect on protein structure, stability, and liposome physicochemical characteristics.蛋白抗原吸附到 DDA/TDB 脂质体佐剂上:对蛋白结构、稳定性和脂质体物理化学特性的影响。
Pharm Res. 2013 Jan;30(1):140-55. doi: 10.1007/s11095-012-0856-8. Epub 2012 Sep 6.
8
Pegylation of DDA:TDB liposomal adjuvants reduces the vaccine depot effect and alters the Th1/Th2 immune responses.聚乙二醇化 DDA:TDB 脂质体佐剂可降低疫苗储库效应并改变 Th1/Th2 免疫应答。
J Control Release. 2012 Feb 28;158(1):72-7. doi: 10.1016/j.jconrel.2011.10.012. Epub 2011 Oct 18.
9
Effect of incorporating cholesterol into DDA:TDB liposomal adjuvants on bilayer properties, biodistribution, and immune responses.将胆固醇掺入DDA:TDB脂质体佐剂对双层性质、生物分布和免疫反应的影响。
Mol Pharm. 2014 Jan 6;11(1):197-207. doi: 10.1021/mp400372j. Epub 2013 Nov 20.
10
Influence of trehalose 6,6'-diester (TDX) chain length on the physicochemical and immunopotentiating properties of DDA/TDX liposomes.海藻糖6,6'-二酯(TDX)链长对二油酰基磷脂酰胆碱/TDX脂质体理化性质及免疫增强特性的影响
Eur J Pharm Biopharm. 2015 Feb;90:80-9. doi: 10.1016/j.ejpb.2014.10.015. Epub 2014 Nov 11.

引用本文的文献

1
Facilitating the use of the target product profile in academic research: a systematic review.促进目标产品特性在学术研究中的使用:系统评价。
J Transl Med. 2024 Jul 29;22(1):693. doi: 10.1186/s12967-024-05476-1.
2
Preparation and Characterization of Novel Polyelectrolyte Liposomes Using Chitosan Succinate Layered over Chitosomes: A Potential Strategy for Colon Cancer Treatment.使用琥珀酸壳聚糖包覆壳聚糖体的新型聚电解质脂质体的制备与表征:一种结肠癌治疗的潜在策略
Biomedicines. 2024 Jan 8;12(1):126. doi: 10.3390/biomedicines12010126.
3
Rational Development of a Carrier-Free Dry Powder Inhalation Formulation for Respiratory Viral Infections via Quality by Design: A Drug-Drug Cocrystal of Favipiravir and Theophylline.

本文引用的文献

1
Designing CAF-adjuvanted dry powder vaccines: spray drying preserves the adjuvant activity of CAF01.设计 CAF 佐剂干粉疫苗:喷雾干燥法保持 CAF01 的佐剂活性。
J Control Release. 2013 May 10;167(3):256-64. doi: 10.1016/j.jconrel.2013.01.031. Epub 2013 Feb 8.
2
Protein antigen adsorption to the DDA/TDB liposomal adjuvant: effect on protein structure, stability, and liposome physicochemical characteristics.蛋白抗原吸附到 DDA/TDB 脂质体佐剂上:对蛋白结构、稳定性和脂质体物理化学特性的影响。
Pharm Res. 2013 Jan;30(1):140-55. doi: 10.1007/s11095-012-0856-8. Epub 2012 Sep 6.
3
Pulmonary vaccine delivery: a realistic approach?
通过质量源于设计理念合理开发用于呼吸道病毒感染的无载体干粉吸入制剂:法匹拉韦与茶碱的药物-药物共晶
Pharmaceutics. 2022 Jan 27;14(2):300. doi: 10.3390/pharmaceutics14020300.
4
Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines.延长吸入药物肺部暴露的药物策略。
Acta Pharm Sin B. 2021 Aug;11(8):2565-2584. doi: 10.1016/j.apsb.2021.05.015. Epub 2021 May 21.
5
Optimizing the Intracellular Delivery of Therapeutic Anti-inflammatory TNF-α siRNA to Activated Macrophages Using Lipidoid-Polymer Hybrid Nanoparticles.使用类脂质-聚合物杂化纳米颗粒优化治疗性抗炎TNF-α siRNA向活化巨噬细胞的细胞内递送
Front Bioeng Biotechnol. 2021 Jan 14;8:601155. doi: 10.3389/fbioe.2020.601155. eCollection 2020.
6
Quality-by-Design Concepts to Improve Nanotechnology-Based Drug Development.基于质量源于设计理念提高纳米技术药物研发水平
Pharm Res. 2019 Sep 3;36(11):153. doi: 10.1007/s11095-019-2692-6.
7
Identification of Factors of Importance for Spray Drying of Small Interfering RNA-Loaded Lipidoid-Polymer Hybrid Nanoparticles for Inhalation.鉴定用于吸入的载小干扰 RNA 的脂质-聚合物杂化纳米粒喷雾干燥的重要因素。
Pharm Res. 2019 Aug 2;36(10):142. doi: 10.1007/s11095-019-2663-y.
8
Process Optimization and Upscaling of Spray-Dried Drug-Amino acid Co-Amorphous Formulations.喷雾干燥药物-氨基酸共无定形制剂的工艺优化与放大
Pharmaceutics. 2019 Jan 9;11(1):24. doi: 10.3390/pharmaceutics11010024.
9
Design space development for the extraction process of Danhong injection using a Monte Carlo simulation method.采用蒙特卡罗模拟方法进行丹红注射液提取工艺的设计空间开发。
PLoS One. 2015 May 28;10(5):e0128236. doi: 10.1371/journal.pone.0128236. eCollection 2015.
10
Unit operation optimization for the manufacturing of botanical injections using a design space approach: a case study of water precipitation.采用设计空间方法对植物提取物注射剂生产进行单元操作优化:水沉淀案例研究
PLoS One. 2014 Aug 7;9(8):e104493. doi: 10.1371/journal.pone.0104493. eCollection 2014.
肺部疫苗传递:现实可行的方法?
J Aerosol Med Pulm Drug Deliv. 2012 Oct;25(5):249-60. doi: 10.1089/jamp.2011.0931. Epub 2012 Aug 2.
4
Design of experiments-based monitoring of critical quality attributes for the spray-drying process of insulin by NIR spectroscopy.基于实验设计的近红外光谱法监测胰岛素喷雾干燥过程的关键质量属性。
AAPS PharmSciTech. 2012 Sep;13(3):747-55. doi: 10.1208/s12249-012-9796-1. Epub 2012 May 15.
5
Design space approach in the optimization of the spray-drying process.设计空间方法在喷雾干燥工艺优化中的应用。
Eur J Pharm Biopharm. 2012 Jan;80(1):226-34. doi: 10.1016/j.ejpb.2011.09.014. Epub 2011 Sep 29.
6
Stabilization of liposomes during drying.脂质体干燥过程中的稳定性。
Expert Opin Drug Deliv. 2011 Mar;8(3):375-88. doi: 10.1517/17425247.2011.553219. Epub 2011 Feb 4.
7
Quality by design approach in the optimization of the spray-drying process.质量源于设计在喷雾干燥工艺优化中的应用。
Pharm Dev Technol. 2012 Jul-Aug;17(4):389-97. doi: 10.3109/10837450.2010.550623. Epub 2011 Jan 29.
8
New developments in dry powder pulmonary vaccine delivery.干粉肺部疫苗递呈的新进展。
Trends Biotechnol. 2011 Apr;29(4):191-8. doi: 10.1016/j.tibtech.2010.12.009. Epub 2011 Jan 20.
9
Quality by design for biopharmaceuticals.生物制药的质量源于设计
Nat Biotechnol. 2009 Jan;27(1):26-34. doi: 10.1038/nbt0109-26.
10
Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements.用合成分枝杆菌索状因子配制的阳离子脂质体(CAF01):一种适用于不同免疫需求疫苗的通用佐剂。
PLoS One. 2008 Sep 8;3(9):e3116. doi: 10.1371/journal.pone.0003116.